Rwanda is committed to eliminating cervical cancer by 2027, three years ahead of the World Health Organization's (WHO) global target of 2030, according to the Minister of Health, Dr. Sabin Nsanzimana.

Chris Boshoff, Pfizer’s chief oncology officer Its new ... by 2030, up from around 6% at the moment, where sales are dominated by small molecules like Ibrance (palbociclib) for breast cancer ...

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

But what do these new technologies look like? And how might they change oncology for the better? Cancer detection technology is critically important for preventing and mitigating the effects of this ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

Scientists from KAIST have developed technology that can transform cancer cells into normal cells, offering a potentially new approach to cancer therapies. Researchers from the Korean Advanced ...

Jan. 30, 2025 — A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work ...

The "Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis by Product, Procedure Type, End-use, and Region, 2025-2030" report has been added to ResearchAndMarkets.com's ...

Asia accounts for 22 per cent of global healthcare spending despite being home to 60 per cent of the global population ...